Skip to content
value.today
LifeMD, Inc. logo

LifeMD, Inc.

LFMD
$112 Mmarket cap on Oct 30, 2026-63.1% since Jan 2024
Compare
World rank
#18,319
Revenue
$194 M
For year ending December-2025
Net income
$14 M
7.4% margin
SEC filing
Employees
389
As of December 31, 2025
SEC filing

LifeMD, Inc. in brief

LifeMD, Inc. is a listed company in the Retail - Pharmacy industry, based in New York, New York, USA. Its market value was $112 M on 30 October 2026, which makes it the 18,319th largest listed company in the world and the 3,466th largest in the USA on this site. In the year to December 2025 it had sales of $194 M and a net profit of $14 M, about 7 cents of profit for every dollar of sales. It employs about 389 people and Justin Schreiber is its chief executive. Its largest business segments by sales in 2025 were Telehealth (100%) and Telehealth Subscription Revenue (58%). Its shares trade under the symbol LFMD (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About LifeMD, Inc.

LifeMD is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. We believe the traditional healthcare model requiring patients to visit a physician’s office, travel to a retail pharmacy, and return for follow-up appointments or prescription refills is complex, inefficient, and costly which can discourage individuals from seeking necessary medical care and medications. At the same time, the United States continues to experience shortages in primary care key specialty areas.

From the company's annual report filed with the US SEC: read the report

LifeMD, Inc. timeline

4 events, 2012–2025
  1. 2012
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2018
  4. ✎
    Renamed Conversion Labs, Inc.
    Formerly Immudyne, Inc..
  5. 2021
  6. ✎
    Renamed LifeMD, Inc.
    Formerly Conversion Labs, Inc..
  7. 2025
  8. 💰
    Record revenue of $194 million
    FY2025, the highest of the 8 years on record.

Events of LifeMD, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$82 M$164 M$246 M$328 M2023202420252026

World rank over time

▲ up 3,818 places since 2022
2022-01-07: #22175#22,17520222022-12-25: #23929#23,92920222023-07-30: #19488#19,48820232024-01-05: #15702#15,70220242026-03-08: #9464#9,46420262026-08-01: #15954#15,95420262026-10-13: #18049#18,04920262026-10-30: #18357#18,3572026

Rank in USA: #4,306 (Jan 2022) · #4,614 (Dec 2022) · #3,844 (Jul 2023) · #2,914 (Jan 2024) · #1,824 (Mar 2026) · #3,192 (Aug 2026) · #3,377 (Oct 2026) · #3,469 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
0.6×
Price / book
6.1×
Free cash flow yield
5.7%
Net margin (TTM)
-0.2%
Operating margin
-4.0%
Return on equity
-2.1%
Liabilities / assets
71.2%
Revenue growth
+25.3%
R&D / revenue
1.6%
Revenue per employee
$499 K
Profit per employee
$37 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $8M, net income $-1M$8MFY18Fiscal year ending Dec 2019: revenue $12M, net income $-3M$12MFY19Fiscal year ending Dec 2020: revenue $37M, net income $-59M$37MFY20Fiscal year ending Dec 2021: revenue $93M, net income $-61M$93MFY21Fiscal year ending Dec 2022: revenue $119M, net income $-46M$119MFY22Fiscal year ending Dec 2023: revenue $153M, net income $-21M$153MFY23Fiscal year ending Dec 2024: revenue $155M, net income $-21M$155MFY24Fiscal year ending Dec 2025: revenue $194M, net income $14M$194MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$194M+25.3%$-8M$14M7.4%
Dec 2024$155M+1.5%$-20M$-21M-13.8%
Dec 2023$153M+28.2%$-14M$-21M-13.5%
Dec 2022$119M+28.2%$-43M$-46M-38.3%
Dec 2021$93M+149.1%$-54M$-61M-65.6%
Dec 2020$37M+199.0%$-58M$-59M-157.3%
Dec 2019$12M+49.9%$-3M$-3M-25.2%
Dec 2018$8M—$-2M$-1M-14.9%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$8M$2M$6M$0.25—
Dec 2024$18M$1M$16M$-0.60—
Dec 2023$9M$0M$9M——
Dec 2022$-23M$0M$-23M——
Dec 2021$-33M$0M$-33M——
Dec 2020$-12M————
Dec 2019$0M————
Dec 2018$-1M————

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$188M
Net income, trailing 12 months
$-0M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $7M, net income $-3M$7MDec ’24Three months to Mar 2025: revenue $51M, net income $-0M$51MMar ’25Three months to Jun 2025: revenue $49M, net income $-2M$49MJun ’25Three months to Sep 2025: revenue $48M, net income $-4M$48MSep ’25Three months to Dec 2025 (from the annual report): revenue $46M, net income $20M$46MDec ’25Three months to Mar 2026: revenue $50M, net income $-9M$50MMar ’26Three months to Jun 2026: revenue $47M, net income $-7M$47MJun ’26Three months to Sep 2026: revenue $45M, net income $-4M$45MSep ’26

Latest quarter to Sep 2026: revenue $45M (-6.5% on a year earlier), net income $-4M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of LifeMD, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$194 M
Operating income
$-8 M
Net income
$14 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$64 M
Total liabilities
$45 M
Total equity
$18 M

As of December-2025

Top 94 institutional investors in LifeMD, Inc.#

As of Sep 30, 2026
94 institutions held 19.4 M shares (about 40.1% of the shares outstanding) on Sep 30, 2026. The ten largest hold 30.4%. Source: SEC Form 13F filings, filed through Nov 18, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in LifeMD, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Federated Hermes, Inc.4,049,974+1,302,319 (+47.40%)8.38%$12 MNov 12, 2026
2BlackRock, Inc.3,020,174-14,361 (-0.47%)6.25%$9 MNov 13, 2026
3Vanguard Capital Management LLC1,718,423-16,333 (-0.94%)3.56%$5 MNov 13, 2026
4State Street Corp1,288,348-30,436 (-2.31%)2.67%$4 MNov 12, 2026
5Geode Capital Management, LLC1,066,623-1,075 (-0.10%)2.21%$3 MNov 6, 2026
6Renaissance Technologies LLC990,725-88,800 (-8.23%)2.05%$3 MNov 12, 2026
7Prescott Group Capital Management, L.L.C.897,2240 (0.00%)1.86%$3 MOct 30, 2026
8Marshall Wace, LLP809,138+251,664 (+45.14%)1.67%$2 MNov 13, 2026
9Tudor Investment Corp Et Al452,659+178,516 (+65.12%)0.94%$1 MNov 16, 2026
10Susquehanna International Group, LLP404,325-73,951 (-15.46%)0.84%$1 MNov 16, 2026
11Morgan Stanley356,343-47,778 (-11.82%)0.74%$1 MNov 13, 2026
12Northern Trust Corp354,331-2,978 (-0.83%)0.73%$1 MNov 16, 2026
13Citadel Advisors LLC333,953+70,482 (+26.75%)0.69%$1 MNov 16, 2026
14Vanguard Fiduciary Trust Co298,503+14,550 (+5.12%)0.62%$1 MNov 13, 2026
15Vanguard Portfolio Management LLC281,885+8,881 (+3.25%)0.58%$1 MNov 13, 2026
16Goldman Sachs Group Inc232,501+132,883 (+133.39%)0.48%$1 MNov 16, 2026
17UBS Group AG219,905+10,262 (+4.89%)0.46%$1 MNov 10, 2026
18Bank of New York Mellon Corp211,298-35,288 (-14.31%)0.44%$1 MNov 5, 2026
19Millennium Management LLC203,699-197,925 (-49.28%)0.42%$1 MNov 16, 2026
20Walleye Capital LLC189,766-134,132 (-41.41%)0.39%$1 MNov 13, 2026
21Barry Investment Advisors, LLC171,8940 (0.00%)0.36%$0 MOct 14, 2026
22Divisadero Street Capital Management, LP135,8260 (0.00%)0.28%$0 MNov 16, 2026
23Charles Schwab Investment Management Inc113,353-30 (-0.03%)0.23%$0 MNov 16, 2026
24Courier Capital LLC108,500-61,500 (-36.18%)0.22%$0 MOct 19, 2026
25Nuveen, LLC106,917+334 (+0.31%)0.22%$0 MNov 10, 2026
Show all 94: investors 26 to 94
Institutional investors 26 to 94 in LifeMD, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26MAI Capital Management100,000-1,627 (-1.60%)0.21%$0 MNov 12, 2026
27Atom Investors LP69,897New0.14%$0 MNov 16, 2026
28Alliancebernstein L.P.63,9600 (0.00%)0.13%$0 MNov 16, 2026
29CIBC World Market Inc.63,700+33,700 (+112.33%)0.13%$0 MNov 10, 2026
30Bridgeway Capital Management, LLC60,700-15,500 (-20.34%)0.13%$0 MNov 16, 2026
31State of Wyoming60,062-5,668 (-8.62%)0.12%$0 MOct 28, 2026
32Quinn Opportunity Partners LLC60,000-29,995 (-33.33%)0.12%$0 MNov 10, 2026
33Empowered Funds, LLC55,000New0.11%$0 MNov 13, 2026
34Bank Of America Corp /de/54,811-206,203 (-79.00%)0.11%$0 MNov 16, 2026
35AQR Capital Management LLC54,794-564,712 (-91.16%)0.11%$0 MNov 16, 2026
36IMC-Chicago, LLC50,234-31,842 (-38.80%)0.10%$0 MNov 5, 2026
37Group One Trading LLC45,777New0.09%$0 MNov 10, 2026
38Rhumbline Advisers45,398-1,295 (-2.77%)0.09%$0 MNov 10, 2026
39Jpmorgan Chase & Co33,965-19,144 (-36.05%)0.07%$0 MNov 12, 2026
40Simplex Trading, LLC32,670-33,762 (-50.82%)0.07%$0 MNov 4, 2026
41Price T Rowe Associates Inc /MD/30,531+1,952 (+6.83%)0.06%$0 MNov 16, 2026
42Quantbot Technologies LP30,363+8,744 (+40.45%)0.06%$0 MNov 12, 2026
43Deutsche Bank AG\29,765-4,244 (-12.48%)0.06%$0 MNov 6, 2026
44Cambridge Investment Research Advisors, Inc.25,500-25,500 (-50.00%)0.05%$0 MNov 2, 2026
45LPL Financial LLC24,687+19 (+0.08%)0.05%$0 MNov 6, 2026
46Dynamic Technology Lab Private Ltd24,258+8,388 (+52.85%)0.05%$0 MNov 13, 2026
47MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.22,481+675 (+3.10%)0.05%$0 MNov 16, 2026
48Invesco Ltd.21,714-414 (-1.87%)0.04%$0 MNov 12, 2026
49Franklin Templeton Inc20,953-34,855 (-62.46%)0.04%$0 MNov 12, 2026
50All Options USA, LLC19,968-17,198 (-46.27%)0.04%$0 MNov 12, 2026
51Royce & Associates LP19,573-616,551 (-96.92%)0.04%$0 MNov 9, 2026
52State of Alaska, Department of Revenue17,501-2,521 (-12.59%)0.04%$0 MOct 15, 2026
53Accurate Wealth Management, LLC16,676New0.03%$0 MOct 20, 2026
54Barclays PLC15,805+9,567 (+153.37%)0.03%$0 MNov 6, 2026
55Corient Private Wealth LP15,1670 (0.00%)0.03%$0 MNov 16, 2026
56Vanguard Global Advisers, LLC14,479+235 (+1.65%)0.03%$0 MNov 13, 2026
57Russell Investments Group, Ltd.14,242-300,528 (-95.48%)0.03%$0 MNov 6, 2026
58Schonfeld Strategic Advisors LLC13,592New0.03%$0 MNov 16, 2026
59Wealthspire Advisors, LLC12,000-49,664 (-80.54%)0.02%$0 MNov 13, 2026
60Magnus Financial Group LLC12,0000 (0.00%)0.02%$0 MOct 21, 2026
61Wells Fargo & Company/mn11,415-25,593 (-69.16%)0.02%$0 MNov 16, 2026
62New York State Common Retirement Fund11,4000 (0.00%)0.02%$0 MNov 17, 2026
63NFSG Corp11,4000 (0.00%)0.02%$0 MOct 15, 2026
64Police & Firemen's Retirement System of New Jersey11,0320 (0.00%)0.02%$0 MNov 9, 2026
65Jump Financial, LLC10,153-61,065 (-85.74%)0.02%$0 MNov 13, 2026
66Chapin Davis, Inc.10,000New0.02%$0 MOct 9, 2026
67Tower Research Capital LLC (TRC)9,943+4,847 (+95.11%)0.02%$0 MNov 16, 2026
68BNP Paribas Financial Markets9,610+3,856 (+67.01%)0.02%$0 MNov 12, 2026
69FMR LLC6,341-3,060 (-32.55%)0.01%$0 MNov 10, 2026
70Ameritas Investment Partners, Inc.3,3990 (0.00%)0.01%$0 MNov 13, 2026
71Legal & General Group Plc3,3520 (0.00%)0.01%$0 MNov 16, 2026
72Jones Financial Companies Lllp3,1280 (0.00%)0.01%$0 MNov 13, 2026
73Royal Bank Of Canada2,093-746 (-26.28%)0.00%$0 MNov 16, 2026
74Citigroup Inc2,015-16,730 (-89.25%)0.00%$0 MNov 4, 2026
75Global Retirement Partners, LLC1,9000 (0.00%)0.00%$0 MNov 10, 2026
76Summit Securities Group LLC1,283New0.00%$0 MNov 5, 2026
77Sterling Capital Management LLC1,188+861 (+263.30%)0.00%$0 MOct 22, 2026
78GAMMA Investing LLC1,184+500 (+73.10%)0.00%$0 MOct 8, 2026
79IAG Wealth Partners, LLC1,0000 (0.00%)0.00%$0 MNov 6, 2026
80SBI Securities Co., Ltd.975+1 (+0.10%)0.00%$0 MOct 22, 2026
81California State Teachers Retirement System5530 (0.00%)0.00%$0 MNov 13, 2026
82Leonteq Securities AG5140 (0.00%)0.00%$0 MOct 29, 2026
83MassMutual Private Wealth & Trust, FSB430+337 (+362.37%)0.00%$0 MOct 5, 2026
84Arax Advisory Partners359-3,968 (-91.70%)0.00%$0 MNov 12, 2026
85Robinhood Markets, Inc.274—0.00%$0 MNov 18, 2026
86Caitong International Asset Management Co., Ltd213-2,672 (-92.62%)0.00%$0 MOct 29, 2026
87EverSource Wealth Advisors, LLC104-685 (-86.82%)0.00%$0 MNov 4, 2026
88IFP Advisors, Inc1000 (0.00%)0.00%$0 MOct 16, 2026
89Centerpoint Advisors, LLC1000 (0.00%)0.00%$0 MNov 5, 2026
90Meriwether Wealth & Planning, LLC60New0.00%$0 MOct 13, 2026
91PNC Financial Services Group, Inc.47-400 (-89.49%)0.00%$0 MNov 6, 2026
92Essential Partners LLC32-370 (-92.04%)0.00%$0 MOct 14, 2026
93Osaic Holdings, Inc.5New0.00%$0 MNov 12, 2026
94SJS Investment Consulting Inc.4-111 (-96.52%)0.00%$0 MOct 26, 2026

Mutual funds holding LifeMD, Inc.#

93 funds hold shares worth $37 M (about 19.4% of the company). Since their previous reports 39 added shares and 18 sold, buying $8 M net.
Mutual funds holding LifeMD, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Federated Hermes MDT Small Cap Core FundFederated Hermes MDT Series1.58 M$6 M3.3%0.25%+240%Jul 31, 2026
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.1.22 M$5 M2.5%<0.01%+8.6%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors1.04 M$4 M2.2%<0.01%+7.3%Jun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC687,863$3 M1.4%0.03%+116%Jun 30, 2026
🇺🇸 Federated Hermes MDT Small Cap Growth FundFederated Hermes MDT Series796,877$3 M1.6%0.33%+142%Jul 31, 2026
🇺🇸 State Street SPDR S&P Kensho New Economies Composite ETFSSGA Funds Management, Inc.529,988$2 M1.1%0.08%+68%Jun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.475,103$2 M0.98%<0.01%−4.1%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC437,857$2 M0.91%<0.01%+11%Jul 31, 2026
🇺🇸 Royce Small-Cap Opportunity FundRoyce & Associates, LP295,103$1 M0.61%0.09%−52%Jun 30, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors284,395$1 M0.59%<0.01%+31%Jun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC227,637$1 M0.47%<0.01%−1.1%May 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.205,038$1 M0.42%<0.01%+6.1%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors135,043$1 M0.28%0.04%+37%Jun 30, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC86,955$0 M0.18%<0.01%+43%Jun 30, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors82,221$0 M0.17%<0.01%−24%Jun 30, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.93,096$0 M0.19%<0.01%+11%Jul 31, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC73,455$0 M0.15%<0.01%no changeMay 31, 2026
🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC70,500$0 M0.15%0.20%no changeJun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC64,000$0 M0.13%<0.01%+7.2%May 31, 2026
🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors59,470$0 M0.12%<0.01%+2.3%Jun 30, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.56,925$0 M0.12%0.02%+1.3%May 31, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC54,609$0 M0.11%<0.01%+16%Jul 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC43,866$0 M0.09%<0.01%no changeJun 30, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC47,758$0 M0.10%<0.01%no changeJul 31, 2026
🇺🇸 PACE Small/Medium Co Growth Equity InvestmentsUBS Asset Management (Americas) LLC45,331$0 M0.09%0.06%newJul 31, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC38,330$0 M0.08%<0.01%+33%Jun 30, 2026
🇺🇸 Venerable US Small Cap FundVenerable Investment Advisers, LLC33,523$0 M0.07%0.09%−14%Jun 30, 2026
🇺🇸 JPMorgan Diversified Return U.S. Small Cap Equity ETFJ.P. Morgan Investment Management Inc.38,666$0 M0.08%0.02%−2.8%Jul 31, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC28,129$0 M0.06%<0.01%+32%Jun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC26,844$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation27,500$0 M0.06%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.25,459$0 M0.05%<0.01%+3.1%May 31, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC25,630$0 M0.05%<0.01%+60%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.21,590$0 M0.04%<0.01%+27%Jun 30, 2026
🇺🇸 Franklin U.S. Small Cap Equity FundFRANKLIN TEMPLETON FUND ADVISER, LLC20,419$0 M0.04%0.06%no changeJun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.19,914$0 M0.04%<0.01%−6.9%Jun 30, 2026
🇺🇸 AVIP BlackRock Advantage Small Cap Growth PortfolioCONSTELLATION INVESTMENTS INC19,161$0 M0.04%0.06%no changeJun 30, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC22,372$0 M0.05%<0.01%+16%Jul 31, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.18,519$0 M0.04%<0.01%−22%Jun 30, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.20,209$0 M0.04%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.16,333$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC19,197$0 M0.04%<0.01%+14%Jul 31, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company14,010$0 M0.03%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC14,002$0 M0.03%<0.01%−4.3%Jun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC13,749$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.12,700$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC14,815$0 M0.03%<0.01%−4.9%Jul 31, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC10,237$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.8,950$0 M0.02%<0.01%+12%May 31, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC9,114$0 M0.02%0.02%+25%Jun 30, 2026
🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc.9,076$0 M0.02%<0.01%−4.5%Jun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC8,850$0 M0.02%<0.01%+17%Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC8,644$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS7,304$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC7,027$0 M0.01%<0.01%+7.4%Jul 31, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION5,700$0 M0.01%<0.01%no changeMay 31, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.5,697$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC5,455$0 M0.01%<0.01%+37%Jun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC4,880$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.4,721$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC4,699$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC5,464$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC4,196$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC3,931$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.4,582$0 M<0.01%<0.01%+1.0%Jul 31, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC4,409$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC4,210$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management3,399$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC3,071$0 M<0.01%<0.01%+45%Jun 30, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC3,050$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC3,031$0 M<0.01%<0.01%+15%Jun 30, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC2,948$0 M<0.01%<0.01%+22%Jun 30, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS3,316$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.2,466$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC2,862$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC2,613$0 M<0.01%<0.01%+27%Jul 31, 2026
🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC2,005$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC1,872$0 M<0.01%<0.01%+10%May 31, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC1,463$0 M<0.01%<0.01%−40%May 31, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC1,475$0 M<0.01%<0.01%−39%May 31, 2026
🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC1,411$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC1,245$0 M<0.01%<0.01%−5.3%May 31, 2026
🇺🇸 PD Small-Cap Value Index PortfolioPacific Life Fund Advisors LLC1,285$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 VIP Total Market Index PortfolioFidelity Management & Research Company LLC1,204$0 M<0.01%<0.01%+48%Jun 30, 2026
🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc.944$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC841$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC829$0 M<0.01%<0.01%−8.3%Jun 30, 2026
🇺🇸 TIAA Separate Account VA-1 - Stock Index AccountTeachers Advisors, LLC796$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Small-Cap Equity PortfolioPacific Life Fund Advisors LLC617$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Nuveen Life Stock Index FundTeachers Advisors, LLC529$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 State Street Balanced Index FundSSGA Funds Management, Inc.320$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 SmallCap Value Fund IIPrincipal Global Investors, LLC268$0 M<0.01%<0.01%−35%Jul 31, 2026
🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC225$0 M<0.01%<0.01%+13%Jul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 93 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at LifeMD, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$54 K
1 sale, 1 insider
Net, 12 months
-$54 K
open market only
Insiders on file
29
since
$15 K-$3.2 M$0Sep 2024: bought $15 K (1 trades), sold $0 (0 trades)Sep 24Dec 2024: bought $0 (0 trades), sold $163 K (1 trades)Jan 2025: bought $0 (0 trades), sold $130 K (1 trades)Jan 25Feb 2025: bought $0 (0 trades), sold $378 K (1 trades)Mar 2025: bought $0 (0 trades), sold $170 K (1 trades)MarApr 2025: bought $0 (0 trades), sold $389 K (1 trades)May 2025: bought $0 (0 trades), sold $188 K (2 trades)MayJun 2025: bought $0 (0 trades), sold $3.2 M (5 trades)Jul 2025: bought $0 (0 trades), sold $584 K (2 trades)JulSep 2025: bought $0 (0 trades), sold $444 K (1 trades)Dec 2025: bought $0 (0 trades), sold $54 K (1 trades)Dec
Bought (open market)Sold (open market)Hover a month for the totals
LifeMD, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Joan LarovereDirectorGrant or award+35,000——142,050Form 4
filed John R. Strawn Jr.DirectorGrant or award+35,000——498,001Form 4
filed Calum Archibald MacraeDirectorGrant or award+35,000——73,865Form 4
filed Joseph DiTrolioDirectorGrant or award+35,000——308,413Form 4
filed Roberto SimonDirectorGrant or award+35,000——288,175Form 4
filed Umesh SripadChief Technology OfficerGrant or award+75,000——75,000Form 4
filed Atul KavthekarChief Financial OfficerGrant or award+337,500——337,500Form 4
filed John R. Strawn Jr.DirectorGrant or award+50,000——463,001Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: LifeMD, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
7.2 M
15.5% of shares · 10.82 days to cover
Buybacks, Q3 2025
$0.3M
Q3 2025
Shares sold short, last 24 reportsAll stocks →
LifeMD, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q3 2025Q3 2025$0.3M

Fails to deliver

  • : 7,759 shares at $2.32
  • : 10,728 shares at $2.12
  • : 4,827 shares at $2.17
  • : 353 shares at $2.14
  • : 51,002 shares at $2.34

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

LifeMD, Inc. scorecard#

Passes 18 of the 26 checks that could be worked out: strongest in growth (6 of 6), weakest in valuation (3 of 6). Fiscal year 2025; market cap of Oct 30, 2026.

  • Valuation3 of 6
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✗Price to book below its peers' median6.1×Price to book 6.1× against Healthcare's median of 3.1×.
    • ✓Price to sales below its peers' median0.6×Price to sales 0.6× against Healthcare's median of 3.8×.
    • ✓Free cash flow yield above 5%5.7%Free cash flow is 5.7% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • ✓The price assumes slower growth than the last three years'-0.5%The price assumes -0.5% a year for ten years; revenue grew 17.7% a year over the last three.
  • Growth6 of 6
    • ✓Revenue grew in the newest year25.4%Revenue up 25.4% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years17.7%17.7% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median17.7%17.7% a year against Retail - Pharmacy's median of 0.4% (6 companies).
    • ✓Earnings per share grew in the newest year0.25 vs -0.60Diluted EPS 0.25 in fiscal 2025 against -0.60 the year before (report's currency).
    • ✓Net income higher than five years earlier$14 M$14 M in fiscal 2025 against -$59 M in 2020.
    • ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
  • Profitability3 of 5
    • ✓Profitable in the newest year$14 MNet income $14 M in fiscal 2025.
    • ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-4.0%-4.0% against Retail - Pharmacy's median of -2.4% (7 companies).
    • ✓Return on equity above 15%310.3%310.3% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier-4.0%-4.0% in fiscal 2025 against -36.5% in 2022.
  • Financial health2 of 4
    • ✓Short-term assets cover short-term liabilities1.1×Current ratio 1.14 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • ✗Operating income covers interest five times-5.6×Operating income -5.6 times interest in fiscal 2025.
    • ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone-0.90Z-score -0.90 (distress zone) for fiscal 2025.
  • Shareholder returns4 of 5
    • ✓Pays a dividendYesPaid dividends in fiscal 2025.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • ✓Dividends under 75% of net income21.7%Dividends were 21.7% of net income in fiscal 2025.
    • ✗Share count up no more than 2% in a year9.6%Diluted shares up 9.6% in fiscal 2025.
    • ✓Dividends and buybacks above 3% of the market value3.0%Dividends and buybacks were 3.0% of the market value.
    • ✓Free cash flow covers dividends and buybacks$6 MFree cash flow $6 M against $3 M paid out in fiscal 2025.

Worked out from the statements as filed (sec), the medians of Retail - Pharmacy, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from LifeMD, Inc.'s statements, beside the median of Retail - Pharmacy.

LifeMD, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-4.0%-2.4%
Net margin7.4%-1.4%
Return on equity310.3%-49.7%
Revenue growth, 3 years a year17.7%0.4%
Revenue growth25.4%8.3%
Free cash flow margin3.3%-0.3%

5of 8on the Piotroski tests of financial strength

  • The share count rose 9.6% in the year.
  • Operating income covers the interest bill only -5.6 times.
  • Revenue has grown 8 years in a row.

LifeMD, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

LifeMD, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue194155r1531199337128.33.7r5.2
Cost of revenue2821r1919188.9r2.5r2.0r1.0r1.9
Gross profit166133r1341007528r9.9r6.3r2.7r3.3
Selling and marketing8670r76788339r8.9r5.1——
General and administrative5858r524740r45r2.42.3r0.7r1.0
Operating expenses174154r14814412986r13r8.4r3.9r4.5
Operating income−7.7−20r−14−43−54−58−2.9−2.1−1.2r−1.2
Interest expense and finance costs1.42.2r2.61.33.01.70.80.40.10.0
Other non-operating income (expense)—————−2.6−0.8—−1.2−1.2
Income before tax−10−23r−17−45−61−60−3.7−2.4r−1.4−1.2
Income tax0.00.6r0.40.40.00.1−0.1−0.1——
Income from continuing operations−10−23————————
Income from discontinued operations262.3—————0.9r0.2—
Net income including minority interests16−21r−18−45−61−61−3.5−1.4r−1.2−1.2
Minority interests' share of net income1.30.5r2.80.5−0.4−1.9−0.4−0.1−0.0−0.1
Net income attributable to shareholders14−21r−21−46−61−59−3.1−1.2r−1.2−1.1
Earnings per share, basic0.25-0.60——————-0.03-0.03
Earnings per share, diluted0.25-0.60——————-0.03-0.03
Shares, weighted average (basic)4541343127149.9r444233
Shares, weighted average (diluted)4541343127149.9r444233
Balance sheet
Cash and cash equivalents3735334.0419.21.10.20.10.2
Receivables2.5r10r6.3r2.81.01.0r0.10.10.1r0.4
Inventory2.82.82.83.71.61.31.01.00.7r0.2
Other current assets2.63.0r0.90.70.80.20.40.3——
Current assets45r52r43114512r2.71.61.30.8
Property, plant and equipment2.41.4r0.50.50.2—————
Right-of-use (leased) assets5.36.2r0.61.21.80.30.0———
Goodwill———8.0r0—————
Other intangible assets0.30.1r3.03.80.00.30.71.0——
Non-current assets192416145.01.00.71.0——
Total assets64r76r58265013r3.42.61.30.8
Accounts payable1411r11109.110r3.10.90.4r0.8
Current liabilities40r67r35312314r4.01.20.61.2
Lease liabilities (non-current)5.76.3r0.10.61.20.2————
Total liabilities45r84r53332414r4.61.80.6—
Retained earnings−233r−240r−214−191−142−80−17−12−11−9.7
Shareholders' equity18r−9.1r3.5−1123−2.3−1.00.90.9−0.4
Minority interests—1.5r2.1−0.5−1.0−2.2−0.1−0.1−0.3−0.0
Total equity18r−11r4.2r−1222−4.5−1.1r0.80.6−0.4
Total liabilities and equity64r76r58265013r3.42.61.30.8
Shares outstanding47423831312311r454435
Cash-flow statement
Share-based compensation1012121412190.70.30.20.6
Cash from operating activities8.3188.8−23−33−120.3−0.9r−0.8−0.4
Capital expenditure−1.9−1.5r−0.2−0.4−0.2—————
Intangible assets bought—−0.0−0.1−4.0−0.0——−0.1——
Acquisitions, net of cash acquired———−1.0———−0.1——
Cash from investing activities6.9−12−8.7−14−3.4−0.8−0.10.1——
Debt issued————15—————
Debt repaid−19———−15—−0.3———
Shares issued8.7—10—0.52.30.3—0.7r−0.1
Shares bought back−0.3———————−0.1—
Dividends paid−3.1−3.1−3.1−3.1−0.9—————
Cash from financing activities−13−4.129−0.569210.80.80.80.4
Change in cash1.81.929−37328.10.90.0−0.0−0.1
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What LifeMD, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Business segments

  • Telehealth$194 M100%
  • Telehealth Subscription Revenue$113 M58%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Executive pay at LifeMD, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$777 K
Mr. Schreiber
Other top executives, average
$1.6 M
the CEO earned 0.5× this
$100 invested is now
$52
LifeMD, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Mr. Schreiber$777 K$777 K$1.6 M$52
2024Mr. Schreiber$1.1 M$1.1 M$1.1 M$63
2023Mr. Schreiber$889 K$948 K$2.1 M$106

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at LifeMD, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Auditor changedFiling
  • Auditor changedFiling

Auditor changed 2 · Acquisition or sale completed 1 · Directors and officers 7 · Material agreement 3 · New debt 2 · Unregistered share sale 2 · Shareholder vote 2 · Results announced 8

LifeMD, Inc.: events reported to the SEC
FiledWhat happenedFiling
Material agreementNew debtUnregistered share saleResults announced8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Material agreementNew debt8-K
Results announced8-K
Acquisition or sale completedMaterial agreement8-K
Auditor changed8-K
Results announced8-K
Directors and officers8-K
Shareholder vote8-K
Results announced8-K
Auditor changed8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K
Directors and officers8-K
Directors and officersShareholder vote8-K
Directors and officers8-K
Unregistered share sale8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026

Acquisitions and funding#

Private share sales · funding history

Private share sales of LifeMD, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2020$16 MPrivate placement after listing$10 to $50 million23equity, optionsSEC
Aug 2020$4 MPrivate placement after listing$2 to $10 million1equity, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

H-1B hiring at LifeMD, Inc.#

3 labor condition applications certified in fiscal 2026 for 3 positions, at a median wage of $140 K a year.

Certified, FY2026
3
#1,362 among companies on value.today
Worker positions
3
Median wage offered
$140 K
a year, full-time
Applications filed
4
LifeMD, Inc.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
Search Engine Optimization ManagerSearch Marketing Strategists2$140 K
Senior Manager, Financial Planning & AnalysisFinancial Managers1$165 K

Where: New York, NY 3

LifeMD, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202633$140 K4
FY202511$140 K1
FY202322$116 K3

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as LifeMD, Inc

How LifeMD, Inc. compares in Retail - Pharmacy

  • Market cap$112 M · higher than 24% of 35
  • Revenue$194 M · higher than 8% of 38
  • Net margin-0.2% · higher than 20% of 36
  • Revenue growth25.4% · higher than 80% of 11
  • Price / sales0.6× · lower than 58% of 25
  • Price / book6.1× · lower than 18% of 23
  • FCF yield5.7% · higher than 75% of 5

Peer comparison · Retail - Pharmacy

CompanyMarket capP/ENet marginRev. growth
LifeMD, Inc.🇺🇸$112 M—-0.2%+25.4%
Tsuruha Holdings Inc.🇯🇵$6.9 B23.8×2.9%—
Alibaba Health Information Technology Limited🇭🇰$6.7 B24.0×5.7%—
Matsumotokiyoshi Holdings🇯🇵$6.2 B16.5×5.0%—
Yifeng Pharmacy Chain Co., Ltd.🇨🇳$4.3 B17.8×6.9%—
Raia Drogasil S.A.🇧🇷$4.1 B16.8×2.9%—
Selçuk Ecza Deposu Ticaret Ve Sanayi A.S.🇹🇷$3.7 B72.7×3.5%—
Sugi Holdings Co., Ltd.🇯🇵$3.3 B23.6×3.1%—
Cosmos Pharmaceutical Corporation🇯🇵$3.3 B19.5×3.1%—

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of December 31, 2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at LifeMD, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show LifeMD, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about LifeMD, Inc.? Suggest a correction